Close Menu

NEW YORK (GenomeWeb) – Illumina Ventures has raised $230 million for its first fund, which focuses on supporting firms involved in genomics and precision medicine.

Illumina launched the independent, early-stage venture capital firm in 2016 with an investment of $100 million. Since launching, it has raised an additional $130 million from a mix of corporate, institutional, sovereign, and individual investors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.